NIH

COVID-19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network-Based Approach

by

The Future of AI in Personalizing COVID-19 Treatment Recent advancements in artificial intelligence (AI) have shown promising potential in personalizing treatments for COVID-19 patients. A study involving a neural network (NN) to identify which patients would benefit most from remdesivir has sparked hope for more targeted therapeutic strategies. This novel approach could revolutionize how we … Read more

Prehabilitation Program for Lung and Esophageal Cancers (Boosting Recovery and Activity Through Early Wellness): Protocol for a Nonrandomized Trial

by

Revolutionizing Cancer Treatment: The Future of Prehabilitation Prehabilitation is revolutionizing the way we approach cancer treatment. As the leading cause of death in Canada, cancer treatment remains a top priority. With surgical resection being a primary route for treating lung and esophageal cancers, the associated postoperative risks are high, necessitating innovative solutions. Prehabilitation programs like … Read more

Omalizumab treats multi-food allergy better than oral immunotherapy

by

The Advent of Omalizumab in Multi-Food Allergy Treatment The recent findings from a clinical trial led by the National Institutes of Health (NIH) show that omalizumab, known commercially as Xolair, may offer a more effective treatment for multi-food allergies compared to oral immunotherapy (OIT). Remarkably, 36% of those receiving omalizumab could safely consume 2 grams … Read more

Therapy helps peanut-allergic kids tolerate tablespoons of peanut butter

by

Revolutionizing Peanut Allergy Treatments: Promise for High-Threshold Children In a groundbreaking study from February 2025, researchers reported significant strides in treating children with high-threshold peanut allergies. This breakthrough could transform how families manage such allergies, shifting from strict avoidance to potential tolerance development. Impactful Findings from the NIH Study The NIH sponsored study, conducted by … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]